SUMMA, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.387
EU - Europa 777
AS - Asia 581
AF - Africa 18
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.767
Nazione #
US - Stati Uniti d'America 1.358
IT - Italia 585
SG - Singapore 440
CN - Cina 83
IN - India 36
SE - Svezia 31
DE - Germania 30
CA - Canada 29
NL - Olanda 27
FR - Francia 24
CI - Costa d'Avorio 18
RU - Federazione Russa 14
BE - Belgio 13
GB - Regno Unito 13
IE - Irlanda 13
CH - Svizzera 7
FI - Finlandia 6
UA - Ucraina 6
VN - Vietnam 5
IR - Iran 4
JP - Giappone 3
RS - Serbia 3
TW - Taiwan 3
CL - Cile 2
GR - Grecia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
IQ - Iraq 1
KZ - Kazakistan 1
PL - Polonia 1
SI - Slovenia 1
Totale 2.767
Città #
Singapore 355
Millbury 193
Chandler 181
Lawrence 139
Naples 135
Des Moines 94
Santa Clara 78
Ashburn 55
Beijing 55
Wilmington 38
Rome 35
Ottawa 28
Milan 25
Amsterdam 21
Napoli 16
Sant'Arpino 16
Fairfield 15
Brussels 13
Scafati 10
Arezzo 8
Bologna 8
Palermo 8
Augusta 7
Dearborn 7
Shenzhen 7
Siena 7
Greenville 6
Redwood City 6
Bonn 5
Gurgaon 5
Kronberg 5
Rimini 5
Salerno 5
Woodbridge 5
Afragola 4
Ahmedabad 4
Bacoli 4
Baronissi 4
Braunschweig 4
Cava De' Tirreni 4
Dong Ket 4
Dublin 4
Enfield 4
Guangzhou 4
Hangzhou 4
Lappeenranta 4
Maastricht 4
Mondolfo 4
Portici 4
Pune 4
San Mateo 4
Wohlen 4
Ardabil 3
Boston 3
Delhi 3
Fribourg 3
Irpin 3
Jalandhar 3
Leawood 3
Maniago 3
Messina 3
Mugnano di Napoli 3
Nanjing 3
Nocera Superiore 3
Norwalk 3
Palagano 3
Redmond 3
Sarno 3
Seattle 3
Shaoxing 3
Stockholm 3
Torre Annunziata 3
Acquappesa 2
Albano Laziale 2
Ann Arbor 2
Campobasso 2
Catanzaro 2
Chennai 2
Coimbatore 2
Dallas 2
Desio 2
Emeryville 2
Hayes 2
Helsinki 2
Kizuki-sumiyoshicho 2
Kunming 2
Limatola 2
London 2
Matera 2
Mohali 2
Mumbai 2
New Taipei City 2
Noida 2
Nola 2
Novi Sad 2
Oristano 2
Perugia 2
Pisciotta 2
Pomigliano d'Arco 2
Qualiano 2
Totale 1.784
Nome #
6-Bromoindirubin-3′-oxime intercepts GSK3 signaling to promote and enhance skeletal muscle differentiation affecting miR-206 expression in mice 70
Anti-inflammatory and immunomodulatory activity of Mangifera indica L. reveals the modulation of COX-2/mPGES-1 axis and Th17/Treg ratio 50
Preparation of arylaminocarbonyl pyrrolo-​fused tricyclic sulfonamides as inhibitors of hepatitis B virus 48
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 48
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities 46
A Focus on Severe Acute Respiratory Syndrome ( SARS ) Coronavirus ( SARS‐CoVs ) 1 and 2 44
Bicyclic pyrimidones as inhibitors of HIV-​integrase 43
Phytochemical investigation and antioxidant properties of unripe tomato cultivars (Solanum lycopersicum L.) 42
Visible-light photocatalytic functionalization of isocyanides for the synthesis of secondary amides and ketene aminals 39
Easy access to α-ketoamides as SARS-CoV-2 and MERS Mpro inhibitors via the PADAM oxidation route 38
Continuous-Flow Technology for Chemical Rearrangements: A Powerful Tool to Generate Pharmaceutically Relevant Compounds 36
3-​Hydroxy-​4-​oxo-​4H-​pyrido[1,​2-​a]​pyrimidine-​2-​carboxylates-​A new class of HIV-​1 integrase inhibitors 35
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells 35
Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination 34
Synthesis and SAR of 2-​(4,​5-​dihydroxy-​6-​carboxy-​pyrimidinyl) thiophenes as inhibitors of the Hepatitis C Virus NS5B Polymerase 34
3-​Hydroxy-​4-​oxo-​4H-​pyrido[1,​2-​a]​pyrimidine-​2-​carboxylates; fast access to a heterocyclic scaffold for HIV-​1 integrase inhibitors 34
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology 34
Antiviral agents for the treatment of hepatitis C virus infections 32
Thinned Nectarines, an Agro-Food Waste with Antidiabetic Potential: HPLC-HESI-MS/MS Phenolic Characterization and In Vitro Evaluation of Their Beneficial Activities 32
4,​5-​Dihydroxypyrimidine Carboxamides and N-​Alkyl-​5-​hydroxypyrimidinone Carboxamides Are Potent, Selective HIV Integrase Inhibitors with Good Pharmacokinetic Profiles in Preclinical Species 30
Chiral Azole Derivatives. 2. Synthesis of Enantiomerically Pure 1-​Alkylimidazoles 30
Rejuvenating the [1, 2, 3]-triazolo [1,5-a]quinoxalin-4(5H)-one scaffold: Synthesis and derivatization in a sustainable guise and preliminary antimicrobial evaluation 29
4-​Hydroxy-​5-​pyrrolinone-​3-​carboxamide HIV-​1 integrase inhibitors 29
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities 29
Heterocyclic compounds used in the treatment of kinetoplastid infection and their preparation 28
Preparation of arylaminocarbonyl bicyclic sulfonamides as inhibitors of hepatitis B virus 27
Photo-Flow Technology for Chemical Rearrangements: A Powerful Tool to Generate Pharmaceutically Relevant Compounds 26
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction 25
Preparation of heteroaryl heptanamide derivatives for use in the treatment of parasitic diseases 24
Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: Structure-​based design and synthesis of new templates 24
Preparation of arylaminocarbonyl bicyclic sulfonamides as inhibitors of hepatitis B virus 24
Improved Selective Class i HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides 23
Preparation of dihydroxypyridinylpyrimidinecarboxamide derivatives for use as HIV-​1 nucleocapsid inhibitors 23
Aryl propargylic alcohols of high enantiomeric purity via lipase catalyzed resolutions 23
Advances in the development of macrocyclic inhibitors of hepatitis C virus NS3-​4A protease 23
Binding of a Noncovalent Inhibitor Exploiting the S' region Stabilizes the Hepatitis C virus NS3 Protease Conformation in the Absence of Cofactor 22
Dermatological and​/or cosmetic peptides for use in skin treatment 22
Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease 22
Application of a Rapid and Simple Technological Process to Increase Levels and Bioccessibility of Free Phenolic Compounds in Annurca Apple Nutraceutical Product 22
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals 22
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort 21
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis 21
Discovery of α,​γ-​Diketo Acids as Potent Selective and Reversible Inhibitors of Hepatitis C Virus NS5b RNA-​Dependent RNA Polymerase 21
Structure-​Based Identification of HIV-​1 Nucleocapsid Protein Inhibitors Active against Wild-​Type and Drug-​Resistant HIV-​1 Strains 21
Preparation of hydroxyoxopyridopyrimidinecarboxamides as HIV integrase inhibitors 21
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen 21
Discovery and Antiviral Profile of New Sulfamoylbenzamide Derivatives as HBV Capsid Assembly Modulators 20
Identification of Isoform 2 Acid-Sensing Ion Channel Inhibitors as Tool Compounds for Target Validation Studies in CNS 20
Early metabolic response to acute myocardial ischaemia in patients undergoing elective coronary angioplasty 19
Development of potent macrocyclic inhibitors of genotype 3a HCV NS3​/4A protease 19
Researches on antiviral agents. 4. Studies on the chemistry of 6-​methyl-​2-​methoxy-​4-​O-​acyloxy and 6-​methyl-​2,​4-​di-​O-​acyloxypyrimidine derivatives as new acylation reagents and inhibitors of uracil DNA glycosylases 19
Hiv integrase inhibitors 19
Preparation of N-​Ph dicarbamate derivatives as HIV reverse transcriptase inhibitors 19
Natural Chalcones for the Management of Obesity Disease 18
Heterocyclic compounds useful in the treatment of disorders that are ameliorated by inhibition of HDAC 18
Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-​4A serine protease and the NS5B RNA-​dependent RNA polymerase 18
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants 18
Compositions useful for the treatment of viral diseases 18
Characterization and quantification of intact glucosinolates in Catozza rapeseeds: A promising food matrix for nutraceuticals development as a source of hydrogen sulfide 17
Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole Derivatives as Antiprotozoal Agents 17
Preparation of macrocyclic peptides as HCV NS3 protease inhibitors 17
A useful methodology for the regioselective deprotection of 1,​3-​dibenzyluracils 17
Studies of metabolism and disposition of potent human immunodeficiency virus (HIV) integrase inhibitors using 19F-​NMR spectroscopy 17
Phosphorous acid analogs of novel P2-​P4 macrocycles as inhibitors of HCV-​NS3 protease 17
A preparation of tetrahydro-​4H-​pyrido[1,​2-​a]​pyrimidine derivatives, useful as HIV integrase inhibitors 17
Preparation of macrocyclic quinoline and naphthyridine peptides as HCV NS3 protease inhibitors useful in the treatment of hepatitis C infection 17
Preparation of macrocyclic quinoxaline peptide as HCV NS3 protease inhibitor 17
Preparation of oxalamido-​substituted tricyclic inhibitors of hepatitis B virus 17
Prdm16-mediated H3K9 methylation controls fibro-adipogenic progenitors identity during skeletal muscle repair 17
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses 16
Validation of an LC-MS/MS Method for the Determination of Abscisic Acid Concentration in a Real-World Setting 16
From dihydroxypyrimidine carboxylic acids to carboxamide HIV integrase inhibitors 16
Discovery of a selective series of inhibitors of Plasmodium falciparum HDACs 16
Preparation of 2-​aryldihydroxypyrimidine-​4-​carboxylic acids as hepatitis C viral polymerase inhibitors 16
A Food-Grade Method for Enhancing the Levels of Low Molecular Weight Proanthocyanidins with Potentially High Intestinal Bioavailability 15
VX-​950 vertex​/mitsubishi 15
Synthesis of aryl 2-​benzofuranyl- and 2-​indolyl(aryl)​carbinols of high enantiomeric purity via palladium-​catalyzed heteroannulation of chiral arylpropargylic alcohols 15
The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3​/4A protease 15
Largazole analogues as histone deacetylases inhibitors and anticancer agents: an overview on structure‐activity relationships 15
The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-​1 integrase inhibitors 15
The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-​dependent RNA polymerase 15
Inhibitors of the Hepatitis C Virus NS3 Protease with Basic Amine Functionality at the P3-​Amino Acid N-​Terminus: Discovery and Optimization of a New Series of P2-​P4 Macrocycles 15
Preparation of quinazolines as antivirals for treatment of hepatitis C viral (HCV) infection 15
Preparation of N-​(4-​fluorobenzyl)​-​5-​hydroxy-​1-​methyl-​2-​(1-​methyl-​1-​[(5-​methyl-​1,​3,​4-​oxadiazol-​2-​yl)​carbonyl]​amino​ethyl)​-​6-​oxo-​1,​6-​dihydropyrimidine-​4-​carboxamide potassium salts as HIV integrase inhibitors 15
Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents 15
Beneficial Contribution to Glucose Homeostasis by an Agro-Food Waste Product Rich in Abscisic Acid: Results from a Randomized Controlled Trial 14
Macrocyclic compounds as antiviral agents 14
Preparation of macrocyclic peptides as HCV NS3 protease inhibitors 14
Preparation of dihydroxypyrimidine carboxamide inhibitors of HIV integrase 14
Development of macrocyclic inhibitors of HCV NS3​/4A protease with cyclic constrained P2-​P4 linkers 14
Novel P2-​P4 macrocyclic inhibitors of HCV NS3​/4A protease by P3 succinamide fragment depeptidization strategy 14
Evaluation of HIV-​1 integrase inhibitors on human primary macrophages using a luciferase-​based single-​cycle phenotypic assay 14
Inhibitors of hepatitis C virus NS3​/4A: α-​Ketoamide based macrocyclic inhibitors 14
Discovery, synthesis and optimization of a new series of selective HIV integrase inhibitors leading to MK-​0518 currently in Phase III clinical trial for treatment of HIV​/AIDS 14
Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: The basis of the genotype 1b vs. 3a inhibitor potency shift 14
Preparation of N-​substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase 14
Diketoacid derivatives as inhibitors of viral polymerases 14
Nucleoside derivatives as inhibitors of viral polymerases 14
Preparation of macrocyclic peptides as HCV NS3 protease inhibitors 13
Identification and Biological Evaluation of a Series of 1H-​Benzo[de]​isoquinoline-​1,​3(2H)​-​diones as Hepatitis C Virus NS5B Polymerase Inhibitors 13
Totale 2.292
Categoria #
all - tutte 15.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020242 0 0 0 0 107 12 25 20 3 14 55 6
2020/2021228 9 2 2 0 15 78 32 7 17 5 32 29
2021/2022570 8 4 7 31 16 18 0 36 22 26 88 314
2022/2023657 143 39 10 53 56 49 57 66 112 17 41 14
2023/2024663 47 67 110 69 27 18 21 47 14 25 147 71
2024/2025600 194 343 34 29 0 0 0 0 0 0 0 0
Totale 2.960